Anodyne Therapy Receives Regulatory Approval from Health Canada for Treatment of Peripheral Neuropathy • Posts by EIM | Evidence In Motion Skip To Content

Anodyne Therapy Receives Regulatory Approval from Health Canada for Treatment of Peripheral Neuropathy

June 7, 2005 • Health Care News • Larry Benz

Link: Anodyne Therapy Receives Regulatory Approval from Health Canada for Treatment of Peripheral Neuropathy.

Anodyne Therapy Receives Regulatory Approval from Health Canada for Treatment of Peripheral Neuropathy

Although this is a press release right from the manufacturer, I am curious as to the market penetration of anodyne in your area. marketing has always outpaced research and Anodyne’s marketing has been impressive, especially amongst the podiatrists. They have even set-up their own “therapy” centers in our market. Is Anodyne a passing fad or just the latest in devices for a difficult patient population-peripheral neuropathies? Please provide feedback.

Larry Benz

Dr. Larry Benz, DPT, OCS, MBA, MAPP, is the Executive Chairman of Confluent Health. He is nationally recognized for his expertise in private practice physical therapy and occupational medicine. Dr. Benz’s current areas of interest include conducting research and integrating empathy, compassion, and positive psychology interventions within physical therapy. He released a book on September...

––– Related Items

––– Post a Comment

— All comments subject to approval

Your email address will not be published. Required fields are marked *

Sign up for news

Join the EIM Mailing List to receive next level updates on research, news, and educational offerings.